Burning Rock Biotech
BNR----
Burning Rock Biotech (BNR)
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three seg...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Burning Rock Biotech Analyst Rating
View MoreForecast & Rating
Sep 22, 2023Price forecast
$39.14337.35%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 18 at 04:13 AM
The Barbell Market of 2026: Balancing Gene Therapies With High-Leverage ETFs
- Global Report · Jul 9 at 05:02 AM
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 Breakouts
- Tip Ranks · Jul 2 at 09:03 PM
Major Insider Move Signals Growing Confidence in Burning Rock Biotech
- benzinga_article · Jul 2 at 01:33 PM
Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72.
- TradingView · Jul 2 at 07:40 AM
Burning Rock Biotech Director Purchased Shares Worth Over $6.1M
- PUBT · Jul 2 at 07:31 AM
Burning Rock Biotech director Han Yusheng reports $6.42 million ADS purchase
